Calan Sr

Calan Sr

Dosage
120mg 240mg
Package
360 pill 180 pill 120 pill 90 pill 60 pill 30 pill
Total price: 0.0
  • In our pharmacy, you can buy Calan SR without a prescription, with delivery in 5–14 days throughout Canada (English). Discreet and anonymous packaging; note that while some pharmacies supply it without a receipt, Calan SR is officially a prescription-only medicine in most countries.
  • Calan SR (verapamil) is used to treat hypertension, angina and certain cardiac arrhythmias; it is a phenylalkylamine calcium‑channel blocker that inhibits L‑type calcium channels, reducing myocardial contractility, vascular resistance and slowing AV nodal conduction.
  • Usual adult doses: hypertension 180–240 mg/day (commonly once daily with ER formulations); angina immediate‑release 80–120 mg three times daily; arrhythmias 240–320 mg/day in divided doses. Lower starting doses are recommended for elderly patients and those with liver impairment.
  • Administered orally as immediate‑release tablets (40, 80, 120 mg) or extended‑release tablets/capsules (120, 180, 240 mg). Do not crush or chew extended‑release forms.
  • Onset of effect: immediate‑release oral tablets typically begin to work within about 30–60 minutes; extended‑release formulations may take 2–4 hours to produce full effect.
  • Duration of action: immediate‑release effects generally last 6–8 hours; extended‑release (Calan SR) is designed for once‑daily dosing with effects lasting up to ~24 hours depending on formulation and dose.
  • Alcohol warning: avoid or limit alcohol while taking verapamil — alcohol can increase drowsiness, worsen hypotension and enhance heart‑rate effects; consult your healthcare provider.
  • The most common side effect is constipation; other frequent adverse effects include dizziness, headache, ankle swelling, nausea and bradycardia.
  • Would you like to try calan sr without a prescription?
Trackable delivery 5-9 days
Payment method Visa, MasterCard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Basic Calan SR Information

  • INN (International Nonproprietary Name): Verapamil
  • Brand Names Available In Canada (English): Isoptin, Isoptin SR, Tarka (combo with trandolapril); Calan SR is marketed in the USA but Isoptin SR and generics are common in Canada
  • ATC Code: C08DA01
  • Forms & Dosages: Immediate-release tablets 40 mg, 80 mg, 120 mg; Extended-release (SR/ER) tablets/capsules 120 mg, 180 mg, 240 mg
  • Manufacturers In Canada (English): Generic suppliers include Mylan, Sandoz, and other generic manufacturers; branded Calan SR marketed by Pfizer in the USA and Isoptin is available in Canada
  • Registration Status In Canada (English): Approved products and generics are registered in major markets; confirm specific product Health Canada approval and DIN on the package
  • OTC / Rx Classification: Prescription-only (Rx) medicine
  • Approved Indications And Dosage Recommendations: Hypertension 180–240 mg/day (divided or ER once daily); Angina pectoris immediate-release 80–120 mg three times daily; Arrhythmias 240–320 mg/day divided
  • Special Populations: Children—rare, weight-based specialist dosing; Elderly—start lower due to sensitivity and hypotension risk; Liver/Kidney Impairment—dose reduction and monitoring advised
  • Treatment Duration & Regimens: Long-term for hypertension and chronic angina; arrhythmia therapy based on specialist review
  • Missed Dose Advice: Take as soon as remembered unless almost time for next dose; do not double dose
  • Overdose Management: Emergency care—severe hypotension, bradycardia, arrhythmia; supportive measures (IV calcium, vasopressors, pacing as needed)
  • Storage: Store at room temperature 15–30°C; keep out of reach of children
  • Absolute Contraindications: Severe hypotension (systolic <90 mmHg), second/third-degree AV block (unless pacemaker), sick sinus syndrome (unless pacemaker), severe heart failure, known hypersensitivity to verapamil or excipients
  • Common Side Effects: Constipation, dizziness, headache, fatigue, peripheral (ankle) edema, nausea, bradycardia

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

Which time of day will fit your life and symptoms?

Many Canadians take verapamil SR once daily in the morning to match daytime activities and routine blood‑pressure checks.

Evening dosing can suit people who experience daytime dizziness or hypotension and want lower daytime effects.

If your prescriber recommends switching from morning to evening, get pharmacist counselling and change the timing gradually rather than skipping doses.

Taking With Or Without Meals (Canadian Diet Context)

Verapamil SR may be taken with or without food, but high‑fat meals can alter absorption for some formulations.

If your typical meals include higher‑fat Canadian comfort foods like poutine or buttered dishes, keep dosing relative to meals consistent to reduce variability.

Do not crush, chew, or split extended‑release (SR/ER) tablets; swallow them whole to preserve controlled release.

Practical Tips:

  • Typical ER strengths: 120 mg, 180 mg, 240 mg once daily—follow your prescription.
  • Set phone alarms tied to habitual triggers (morning coffee, evening supper) for adherence.
  • Use pharmacy blister packs or weekly pill boxes if you take multiple meds.
  • Rural patients can request synchronized monthly pickups or mail-order from their local pharmacy.
  • Track side effects—constipation, ankle swelling, dizziness—in a symptom diary to share at follow‑up.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

People with severe hypotension, advanced AV block unless they have a pacemaker, sick sinus syndrome without a pacemaker, severe heart failure, or known hypersensitivity to verapamil should avoid the drug.

Tell your prescriber if you have liver disease, significant kidney disease, a history of bradycardia, or neuromuscular disorders such as myasthenia gravis.

Activities To Limit (Driving, Workplace Safety)

Verapamil can cause dizziness, lightheadedness, and fatigue; avoid driving or operating heavy machinery until you know how it affects you.

For seasonal or physical tasks such as snow clearing or hiking, check your blood pressure before exertion and pause activity if you feel unsteady.

Alcohol may increase dizziness and hypotension—limit intake until your reaction is known.

Quick Checklist:

  • Baseline BP and heart rate before starting and after dose changes.
  • Avoid driving until tolerance is established.
  • Carry a wallet card stating you take verapamil and list emergency contacts.
  • Inform occupational health or supervisor if your job involves safety‑sensitive duties.

Dosage & Adjustments

General Regimen (DIN References)

Extended‑release verapamil tablets commonly come in 120 mg, 180 mg, and 240 mg strengths for once‑daily dosing.

Immediate‑release forms are usually 40–120 mg and are dosed two to three times daily for angina or certain arrhythmias.

For hypertension, typical ER dosing is 180–240 mg/day, either as a once‑daily ER tablet or divided doses; for arrhythmias dosing often totals 240–320 mg/day divided.

Always confirm the product’s DIN on the label and match the dose to the Health Canada product monograph provided by your pharmacist.

Special Cases (Elderly, Comorbidities)

Start lower in elderly patients because sensitivity and risk of hypotension increase with age.

Reduce dose and monitor closely in significant hepatic impairment; renal impairment usually requires clinical monitoring rather than automatic dose change.

When verapamil is combined with strong CYP3A4 inhibitors (for example certain macrolide antibiotics or azole antifungals) or beta‑blockers, dose reductions and ECG or rate monitoring may be necessary.

Dosing Table:

  • ER (once daily): 120 mg / 180 mg / 240 mg — common for hypertension and maintenance.
  • IR (divided doses): 40 mg / 80 mg / 120 mg — used for angina and some arrhythmias.
  • Adjustments: halve starting dose in frail elderly, reduce with hepatic impairment, monitor with interacting drugs.

User Testimonials

Positive Reports From Canadian Patients

Many patients switching to an SR formulation report better adherence and steadier blood pressure control with fewer daytime chest pain episodes.

Some people report improved sleep when moving dosing to the evening and reduced palpitations after careful titration.

Common Challenges In Forums

Constipation is the most common complaint on community boards such as Reddit Canada and local health forums; simple measures often help.

Other common issues include ankle swelling and a slow heart rate; some patients switch to a different class, like amlodipine, when peripheral oedema is persistent.

Rural patients sometimes report delays obtaining specific brands such as Calan SR and therefore accept generic verapamil SR while confirming DIN and formulation with their pharmacist.

Pros / Cons Summary:

  • Pro: Once‑daily ER convenience and effective BP/angina control.
  • Con: Constipation, bradycardia risk, drug interactions requiring monitoring.

Common Side Effects And Practical Fixes Table:

Side Effect Typical Fix
Constipation Increase dietary fibre, fluids, consider stool softener after pharmacist advice
Ankle Swelling Compression stockings, dose review, consider alternative CCB if persistent
Dizziness/Bradycardia Monitor BP/HR, adjust dose, check for interacting medicines

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Verapamil SR is prescription-only in Canada; fill at national chains like Shoppers Drug Mart, Rexall, London Drugs, Jean Coutu, or your local community pharmacy.

Ask the pharmacist to verify the DIN and show you the product monograph before leaving the pharmacy, especially when accepting a generic substitution.

Price Comparison (In-Store Vs Online, Cross-Border Notes)

Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare, and RAMQ may cover verapamil or its generics for eligible patients—confirm coverage and prior authorization requirements ahead of time.

Generics usually cost less than brand-name products; ask the pharmacist for a price comparison and whether substitution is permitted on your prescription.

Ordering Tips And Safety Checklist:

  • Verify the DIN on the package to ensure the product is approved in Canada.
  • Prefer Canadian online pharmacies tied to brick‑and‑mortar stores to ensure bilingual labelling and authentic DINs.
  • Avoid unapproved foreign products lacking Canadian labelling and DIN—imports may face customs delays and regulatory issues.
  • In our online pharmacy, calan sr can be ordered with a valid prescription and is shipped discreetly across Canada in 5–14 days.

What’s Inside & How It Works

Ingredients Overview

The active ingredient is verapamil, commonly provided as verapamil hydrochloride in tablets or capsules.

Extended‑release tablets contain verapamil plus excipients and release modifiers that control drug release over 24 hours; exact non‑medicinal ingredients vary by manufacturer—check the package insert for allergy information.

Mechanism Basics

Verapamil is a phenylalkylamine calcium‑channel blocker (ATC code C08DA01) that inhibits L‑type calcium channels in cardiac and vascular smooth muscle.

This reduces myocardial contractility, slows AV nodal conduction—useful for some supraventricular arrhythmias—and lowers systemic vascular resistance to reduce blood pressure.

Its combined cardiac and vascular effects distinguish it from dihydropyridine CCBs like amlodipine, which are more vascular selective and tend to cause less bradycardia.

Comparison Table:

Drug Class Main Cardiac Effect Typical Side Effect
Verapamil (Phenylalkylamine) Slows AV conduction, reduces contractility Constipation, bradycardia
Diltiazem (Benzothiazepine) Moderate AV nodal effect Edema, dizziness
Amlodipine (Dihydropyridine) Primarily vasodilation Peripheral edema

Main Indications

Approved Uses In Canada

Verapamil products such as Isoptin SR and generics are approved for hypertension, chronic stable angina, and certain supraventricular arrhythmias.

Typical oral dosing for hypertension is 180–240 mg/day (ER), for angina immediate‑release dosing is 80–120 mg three times daily, and for arrhythmias total daily dosing often ranges 240–320 mg divided.

Confirm the exact indications and doses by checking the product monograph and the DIN on the package supplied by your pharmacy.

Off-Label Uses By Canadian Physicians

Specialist cardiologists may prescribe verapamil off‑label for select arrhythmia scenarios or uncommon disorders where rate control is needed and beta‑blockers are contraindicated, always under specialist supervision.

Paediatric use is rare and reserved for weight‑based specialist dosing for specific arrhythmias.

Monitoring Requirements:

  • Regular blood pressure and heart‑rate checks.
  • ECG when starting or changing dose for arrhythmia patients.
  • Liver function tests as clinically indicated when hepatic impairment is present.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Alcohol can enhance verapamil’s hypotensive and sedative effects and increase dizziness; avoid excess alcohol while initiating or changing dose.

Caffeine does not directly interact with verapamil but can alter heart‑rate sensations—aim for a consistent caffeine intake pattern to reduce symptom variability.

Large calcium supplements may blunt verapamil’s effect—discuss timing and doses of supplements with your clinician.

Drug Conflicts (Health Canada Database)

Verapamil is a substrate and inhibitor of CYP3A4 and has clinically significant drug interactions.

High‑risk interactions include macrolide antibiotics such as clarithromycin, certain azole antifungals, and some protease inhibitors—all can raise verapamil levels and increase bradycardia or hypotension risk.

Combining verapamil with beta‑blockers or digoxin increases risk of AV block and bradycardia; monitoring and dose adjustments are usually required.

Interaction Checklist:

  • Before starting any new prescription, OTC, or herbal product, show your medication list to the pharmacist.
  • Notify clinicians about clarithromycin, ketoconazole, ritonavir, or strong CYP3A4 inhibitors.
  • Avoid St John’s wort which may reduce verapamil levels.

Latest Evidence & Insights

Highlight Canadian And International Research

Clinical evidence supports verapamil’s established role in blood‑pressure control and rate control for certain supraventricular arrhythmias.

Comparative studies highlight differences within the CCB class: verapamil produces more heart‑rate reduction and constipation, while dihydropyridines like amlodipine offer strong vasodilation with more peripheral edema.

Practical Takeaways For Patients:

  • Extended‑release formulations support adherence and more stable blood‑pressure control.
  • Constipation and ankle edema are common but frequently manageable with lifestyle measures or dose changes.
  • Generic verapamil typically matches branded efficacy at lower cost and is commonly listed on provincial formularies as first‑line.

Outcomes Comparison Table:

Measure Verapamil Amlodipine Diltiazem
BP Reduction Good Good Good
Heart Rate Effect Decreases Little Effect Moderate Decrease
Common Adverse Events Constipation, Bradycardia Peripheral Edema Edema, Dizziness

Alternative Choices

List Of Comparable Medicines With Pros/Cons Checklist

Alternatives include diltiazem (Cardizem, Tiazac), dihydropyridine CCBs such as amlodipine (Norvasc), beta‑blockers like metoprolol or atenolol, and ACE inhibitor/ARB classes depending on comorbidities.

Combination products such as Tarka (trandolapril + verapamil) exist in some markets and may simplify therapy when appropriate.

Pros/Cons Checklist:

  • Verapamil: Pro—effective for rate control and arrhythmias; Con—constipation, drug interactions, bradycardia risk.
  • Amlodipine: Pro—potent vasodilation, once daily; Con—more peripheral edema.
  • Diltiazem: Pro—intermediate cardiac/vascular balance; Con—can still cause edema and dizziness.

When To Consider Switching

Consider switching if side effects are intolerable (severe constipation, symptomatic bradycardia), blood pressure remains uncontrolled despite adherence, or interactions make continued use unsafe.

Coordinate changes with your prescriber and pharmacist and monitor BP and heart rate closely for 1–2 weeks after switching.

Regulation Snapshot

Health Canada Approval And DIN Requirements

Verapamil products are prescription‑only in Canada and specific products must be registered with Health Canada and carry a Drug Identification Number (DIN) for dispensing and reimbursement.

Always check the DIN on the package to verify authenticity and coverage eligibility before submitting a claim.

Provincial Coverage And Logistics

Formulary listings vary across provinces; Ontario Drug Benefit, BC PharmaCare, and RAMQ may cover verapamil generics for eligible patients under specific conditions.

Pharmacists can help with prior‑authorization paperwork, suggest generics, and explain substitution policies.

Verification Steps And Checklist:

  • Locate the DIN on your medication label and ask the pharmacist to confirm Health Canada registration.
  • Check provincial formulary coverage and whether a prior authorization is needed.
  • Avoid ordering unapproved foreign products lacking a DIN and Canadian labelling.

FAQ Section

Common Canadian Patient Questions

Q: Can I stop verapamil if I feel better?

A: No—do not stop abruptly; consult your prescriber for a taper plan to avoid rebound tachycardia or uncontrolled blood pressure.

Q: Is verapamil safe during pregnancy or breastfeeding?

A: Verapamil is generally avoided in pregnancy and lactation unless the prescriber judges benefits outweigh risks; specialist assessment is required.

Q: My pharmacy substituted a generic—will it work the same?

A: Generics are bioequivalent to branded products but excipients can differ; verify SR/ER equivalence and check with the pharmacist, especially for mail‑order deliveries to rural areas.

Q: I have constipation—what helps?

A: Increase dietary fibre and fluids, keep active, and consider an OTC stool softener after asking your pharmacist; if severe, discuss dose change with your prescriber.

Red Flags — When To Call A Clinician:

  • Persistent dizziness, syncope, or fainting.
  • Chest pain, shortness of breath, or sudden swelling.
  • Heart rate below 50 bpm with symptoms.

Guidelines For Proper Use

Canadian Pharmacist And Provincial Health Authority Recommendations

Pharmacists should reconcile current medications, confirm the DIN, counsel on SR handling, and advise baseline BP and HR measurements.

Provincial guidance typically recommends follow‑up within 2–4 weeks after initiation or dose change, then periodic monitoring as clinically indicated.

Practical Monitoring Checklist

Baseline: blood pressure, heart rate, medication list review, and ECG if arrhythmia history exists.

Ongoing: BP/HR checks after dose adjustments, liver function tests when hepatic disease is present, and symptom assessment for constipation, ankle edema, and hypotension.

  • Use blister packs or pharmacy packaging to support adherence.
  • Sync refills with provincial dispensing programs to reduce missed doses.
  • Carry a one‑page medication card listing verapamil and other cardiac meds; request bilingual labelling in Quebec if needed.

Delivery Across Canada (English)

City Region Delivery Time
Toronto Ontario 5-7 days
Montreal Quebec 5-7 days
Vancouver British Columbia 5-7 days
Calgary Alberta 5-7 days
Edmonton Alberta 5-7 days
Ottawa Ontario 5-7 days
Winnipeg Manitoba 5-7 days
Halifax Nova Scotia 5-9 days
Saskatoon Saskatchewan 5-9 days
St. John’s Newfoundland and Labrador 5-9 days
London Ontario 5-9 days
Kingston Ontario 5-9 days
Victoria British Columbia 5-9 days
Fredericton New Brunswick 5-9 days

Recently Viewed Products